Rshl2b inhibitors represent a class of chemical compounds that modulate the activity of the Rshl2b protein, a molecular entity involved in cellular processes such as protein-protein interactions and signaling pathways. These inhibitors function by specifically binding to the active or allosteric sites of the Rshl2b protein, disrupting its natural function within the cell. Structurally, Rshl2b inhibitors can be classified into various subgroups, often distinguished by their binding mechanisms, whether reversible or irreversible, and their molecular frameworks. The inhibition of Rshl2b typically results in the modulation of downstream signaling cascades, which may affect cellular responses such as proliferation, differentiation, or apoptosis, depending on the biological context. Chemically, these inhibitors are diverse, ranging from small organic molecules to larger peptides or synthetic compounds, each tailored to interact with different regions of the Rshl2b structure. The design of these inhibitors often involves detailed computational modeling and structure-activity relationship (SAR) studies to optimize their affinity and selectivity for Rshl2b.
The discovery and characterization of Rshl2b inhibitors require extensive biochemical and biophysical research, particularly in understanding how Rshl2b fits within broader protein networks. Techniques such as X-ray crystallography, NMR spectroscopy, and mass spectrometry are commonly used to elucidate the precise molecular interactions between Rshl2b and its inhibitors. Additionally, kinetic studies are important to determine the rate constants and binding affinities of these compounds, giving insights into their potency and effectiveness as molecular probes. Given the potential for these inhibitors to affect specific signaling pathways, their synthesis and optimization involve sophisticated chemical techniques to improve their stability, solubility, and specificity, ensuring that they maintain their structural integrity under various experimental conditions.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
An mTOR inhibitor, affecting cell growth and proliferation, which might be relevant depending on RSHL2B's role in these processes. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $150.00 $388.00 | 113 | |
A kinase inhibitor, broadly affecting signaling pathways, potentially relevant if RSHL2B is part of a signaling cascade. | ||||||
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $62.00 $90.00 $299.00 $475.00 $1015.00 $2099.00 | 69 | |
An immunosuppressant that inhibits calcineurin, potentially affecting pathways if RSHL2B is involved in immune responses. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $30.00 $52.00 $122.00 $367.00 | 25 | |
Disrupts protein trafficking by inhibiting ADP-ribosylation factor, relevant if RSHL2B is involved in vesicular transport. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
A PI3K inhibitor, affecting various signaling pathways, potentially relevant for RSHL2B's function if it's involved in PI3K-related pathways. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
Another PI3K inhibitor, used to study signaling pathways potentially associated with RSHL2B. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $63.00 $241.00 | 136 | |
An inhibitor of MEK, part of the MAPK/ERK pathway, potentially relevant if RSHL2B is involved in this signaling pathway. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
Inhibits p38 MAP kinase, potentially affecting pathways if RSHL2B is linked to stress response signaling. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
A MEK inhibitor, affecting the MAPK/ERK pathway, potentially relevant for RSHL2B-related functions. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $65.00 $267.00 | 257 | |
An inhibitor of JNK, part of the MAPK pathway, which could be relevant if RSHL2B is involved in stress or inflammatory responses. |